Beckman Coulter Life Sciences announces Automata partnership

Beckman Coulter Life Sciences has announced a strategic partnership with London-based lab automation company Automata that will integrate Beckman Coulter Life Sciences liquid handling, genomic and cell analysis technologies with Automata’s AI-ready automation platform with the aim of enabling faster, more consistent and more scalable experimentation for research organisations.

“This partnership reflects our relentless focus on empowering scientists to translate ideas into impact faster,” said Joe Fox, President of Beckman Coulter Life Sciences. “Agentic AI is poised to transform the way wet-lab screening studies are performed. Partnering with Automata allows us to combine our trusted life science tools with cutting-edge automation infrastructure that makes the lab of the future accessible today.”

Through the partnership, Beckman Coulter Life Sciences instruments will be integrated into Automata’s LINQ automation ecosystem — a modular, scalable platform composed of intelligent robotics, unified scheduling software and an agile workflow design environment. LINQ’s cloud-native orchestration engine is engineered to enable laboratories to standardise and automate multistep experimental processes, delivering structured, high-quality datasets that are essential for AI-driven discovery and analysis.

Beckman Coulter Life Sciences is a subsidiary of Danaher Corporation and the partnership is part of a larger investment in which Danaher Ventures will participate in Automata’s Series C funding round and join the company’s board of directors — a move intended to strengthen alignment and long-term support for joint innovation.

Image credit: iStock.com/jittawit.21